Valthos
AI systems that identify biological threats and design medical countermeasures for biodefense organizations
Highlights
- New on EvolcAdded 2026-11-14
About Valthos
Valthos develops AI systems to identify biological threats and design medical countermeasures in real time.
The company is assembling a team and hiring for engineering and operations roles in New York and San Francisco. Its investors include OpenAI, Lux Capital and Founders Fund.
Product: AI systems for identifying biological threats and designing medical countermeasures.
Jobs at Valthos
More ai & ml companies
Vantheon
AI research lab exploring ways to broaden access to investing and wealth creationNew on EvolcVapi
Voice AI agent platform for developers and businesses building automated customer interactionsNew on EvolcVast
GPU cloud marketplace for developers, researchers and AI teams running training, inference and rendering workloadsVerneek
AI-native operating platform connecting merchandising, marketing and store operations for consumer and retail enterprisesNew on EvolcVESSL AI
GPU cloud infrastructure for AI teams training, fine-tuning and serving machine-learning modelsNew on EvolcVidizmo
Secure AI software for government and enterprise teams to manage, analyze, and retrieve insights from unstructured dataNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Frontend frameworks
- Next.jsHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- ReactMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Related technologyimplied by Next.js
Hosting
- VercelHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-vercel-id
Recruiting
- AshbyMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Page markupsoftware structure signature
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.